Icon Wealth Advisors’s Rani Therapeutics RANI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-12,757
Closed -$65.8K – 426
2023
Q1
$65.8K Hold
12,757
– – 0.01% 416
2022
Q4
$75.3K Buy
+12,757
New +$93.1K 0.01% 321

Other funds holding RANI

Icon Wealth Advisors's RANI Position: Q2 2023 in Review

Icon Wealth Advisors sold out of Rani Therapeutics (RANI) in Q2 2023, closing a stake of 12,757 shares — an estimated $65.8K sold.

Icon Wealth Advisors first reported a position in RANI in Q4 2022 and held it in 2 quarters. The position peaked at $75.3K in Q4 2022. 35 funds tracked by Wall St. Rank hold RANI as of Q2 2023.

  • Icon Wealth Advisors reported no remaining Rani Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Icon Wealth Advisors sold 12,757 Rani Therapeutics shares in Q2 2023, an estimated $65.8K.
  • Icon Wealth Advisors first reported a position in Rani Therapeutics in Q4 2022 and held it in 2 quarters.
  • Icon Wealth Advisors's Rani Therapeutics position peaked at $75.3K in Q4 2022.
  • 35 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2023.

Based on Icon Wealth Advisors's 13F filing for Q2 2023, filed 3 Aug 2023.